Beta Bionic, Inc BBNX IPO will take place January, 30 on the NASDAQ exchange under the ticker BBNX.
The company is offering shares at an expected price between $16.00 and $17.00 per share with an insider lock-up period of 180 days ending on July 29, 2025.
See also: Benzinga IPO Calendar
About Beta Bionic, Inc
Beta Bionic, Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring PWD by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.